6. Institute Public Advisory Committees

• National Heart, Lung, and Blood Advisory Council
• National Heart, Lung, and Blood Advisory Council Membership
• Program Advisory and Review Committee
  • Sickle Cell Disease Advisory Committee
  • Sleep Disorders Research Advisory Board
  • Heart, Lung, and Blood Initial Review Group
  • Heart, Lung, and Blood Program Project Review Committee
  • Clinical Trials Review Committee
  • NHLBI Institutional Training Mechanism Review Committee
  • National Heart, Lung, and Blood Institute Special Emphasis Panel
  • Board of Scientific Counselors

National Heart, Lung, and Blood Advisory Council

Structure

Chair:  Elizabeth G. Nabel, M.D., Director, NHLBI

Executive Secretary:  Stephen C. Mockrin, Ph.D., Director, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0260

The Secretary of HHS appoints 18 members:  12 members are leading representatives of the health and scientific disciplines (including public health and behavioral or social sciences), and 6 are from the general public and are leaders in the fields of public policy, law, health policy, economics, and management.

Members are appointed for overlapping terms of 4 years.

The Council includes the following ex officio members:

• Secretary, HHS
• Director, NIH
• Director, NHLBI
• Chief Medical Director, or Designee, Veterans Affairs
• Assistant Secretary of Defense for Health Affairs, or Designee.

Functions

The NHLBAC reviews applications for research grants, cooperative agreements, and training grants in heart, blood vessel, lung, and blood diseases; sleep disorders; and blood resources, and recommends scientific projects that merit support to the Director, NHLBI.

The Council advises the Secretary, HHS; the Assistant Secretary for Health, HHS; and the Directors, NIH and NHLBI on matters relating to causes, prevention, diagnosis, and treatment of diseases and resources within the purview of the Institute.  The Council also may review any grant, contract, or cooperative agreement proposed to be made or entered into by the Institute; may make recommendations to the Director of the Institute respecting research conducted at the Institute; may collect, by correspondence or by personal investigation, information as to studies that are being carried on in the United States or any other country with respect to the cause, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases, and to the use of blood and blood products and the management of blood resources and, with the approval of the Director of the Institute, make available such information through appropriate publications for the benefit of public and private health entities and health professions personnel and scientists and for the information of the general public; and may assemble ad hoc working groups, appoint subcommittees, and convene workshops and conferences.

The Council may also make recommendations to the Director, NIH and other authorized officials regarding the acceptance of conditional gifts pursu-ant to section 231 of the Public Health Service Act, as amended.

Meetings

The Chair convenes meetings not fewer than four times a year and approves the agenda.

National Heart, Lung, and Blood Advisory Council Membership*

Elizabeth G. Nabel, M.D.
Chair
National Heart, Lung, and Blood Institute

Jeanine Arden Ornt, J.D. (2010)
Case Western Reserve University

C. Noel Bairey Merz, M.D. (2011)
Cedars-Sinai Medical Center

Ingrid B. Borercki, Ph.D. (2012)
Washington University in St. Louis

Barry S. Coller, M.D. (2012)
The Rockefeller University

Shaun R. Coughlin, M.D., Ph.D. (2010)
University of California, San Francisco

Victor J. Dzau, M.D. (2009)
Duke University

Jack A. Elias, M.D. (2012)
Yale University School of Medicine

Joe G. N. Garcia, M.D. (2010)
University of Chicago

Helen H. Hobbs, M.D. (2009)
University of Texas Southwestern Medical Center

Beverly W. Hogan (2012)
Tougaloo College

Jennie R. Joe, Ph.D. (2009)
University of Arizona

Joseph Loscalzo, M.D., Ph.D. (2009)
Brigham and Women’s Hospital

Andrew R. Marks, M.D. (2011)
Columbia University

S. K. Rao Musunuru, M.D. (2009)
Bayonet Point/Hudson Cardiology Associates

Michael S. Parmacek, M.D. (2012)
University of Pennsylvania School of Medicine

Paula Y. Polite (2010)
Division of General Services, Memphis

Marlene Rabinovitch, M.D. (2011)
Stanford University

Steven D. Shapiro, M.D. (2010)
University of Pittsburgh

Ex Officio Members

Francis S. Collins, M.D., Ph.D.
National Institutes of Health

William H. Dietz, M.D., Ph.D.
Centers for Disease Control and Prevention

Robert L. Jesse, M.D., Ph.D.
McGuire Veterans Affairs Medical Center

Cdr. Richard T. Mahon, M.D.
Naval Medical Research Center

Kathleen Sebelius, M.P.A.
Department of Health and Human Services

Back to Top

Program Advisory and Review Committee

Sickle Cell Disease Advisory Committee

Chair:  Vacant

Executive Secretary:  W. Keith Hoots, M.D., Division of Blood Diseases and Resources, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0080

The Sickle Cell Disease Advisory Committee advises the Secretary and the Assistant Secretary for Health, HHS and the Directors of the NIH, the NHLBI, and the DBDR on matters related to the Sickle Cell Disease Program and makes recommendations concerning planning, execution, and evaluation of all aspects of the program.

Membership*

Michael A. Bender, M.D., Ph.D. (2010)
Fred Hutchinson Cancer Research Center

Punam Malik, M.D. (2010)
Cincinnati Children’s Hospital Medical Center

Susan P. Perrine, M.D. (2011)
Boston University

Yogen Saunthararajah, M.D. (2011)
Cleveland Clinic

Wally R. Smith, M.D. (2011)
Virginia Commonwealth University

Ex Officio Members

Francis S. Collins, M.D., Ph.D.
National Institutes of Health

Joseph Desimone, Ph.D.
Department of Veterans Affairs, Chicago

Marie Y. Mann, M.D.
Health Resources and Services Administration

David E. McCune, M.D.
Madigan Army Medical Center

Sleep Disorders Research Advisory Board

Chair:  Vacant

Executive Secretary:  Michael J. Twery, Ph.D., Director, National Center on Sleep Disorders Research, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0202.

The Sleep Disorders Research Advisory Board advises the Directors of the NIH, the NHLBI, and the NCSDR on matters related to the scientific activities carried out by and through the Center and policies regarding such activities, including the identification of research priorities for coordination of sleep and sleep disorders research by the NIH and other Federal, professional, and voluntary organizations.

Membership*

Sonia Ancoli-Israel, Ph.D. (2010)
University of California, San Diego School of Medicine

Rose A. Austin (2011)
SSM Healthcare

Karen M. Cushing (2011)
American Insomnia Association

Charles A. Czeisler  M.D., Ph.D. (2011)
Harvard Medical School

Estelle B. Gauda, M.D. (2010)
Johns Hopkins University School of Medicine

F. Javier Nieto, M.D., Ph.D. (2010)
University of Wisconsin School of Medicine

Robert H. Waterman (2011)
The Waterman Group

Ex Officio Members

Thomas J. Balkin, Ph.D.
Walter Reed Army Institute of Research

Francis S. Collins, M.D., Ph.D.
National Institutes of Health

Robert W. Greene, M.D., Ph.D.
Veterans Administration, North Texas Medical Center

Merrill M. Mitler, Ph.D.
NINDS, National Institutes of Health

Andrew Monjan, Ph.D.
NIA, National Institutes of Health

Elizabeth G. Nabel, M.D.
NHLBI, National Institutes of Health

Michael J. Twery, Ph.D.
NCSDR, National Institutes of Health

Marian Willinger, Ph.D.
NICHD, National Institutes of Health

Heart, Lung, and Blood Initial Review Group

Scientific Review Officer:  Jeffery H. Hurst, Ph.D., Health Science Administrator, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0303

The Heart, Lung, and Blood Initial Review Group provides initial technical merit review for the NHLBAC and the Director, NHLBI.  This group consists of three subcommittees:  the Heart, Lung, and Blood Program Project Review Committee; the Clinical Trials Review Committee; and the NHLBI Institutional Training Mechanism Review Committee.

Heart, Lung, and Blood Program Project Review Committee

Chair:  Ann Marie Schmidt, M.D., Columbia University

Scientific Review Officer:  Jeffery H. Hurst, Ph.D., Health Scientist Administrator, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0303

The Heart, Lung, and Blood Program Project Review Committee provides initial technical merit review for the NHLBAC and the Director, NHLBI on program project applications proposing research in the areas of heart, lung, and blood diseases and resources.

Membership*

David Atkinson, Ph.D. (2012)
Boston University School of Medicine

Karen E. Bornfeldt, Ph.D. (2011)
University of Washington

Peng-Sheng Chen, M.D. (2010)
Indiana University School of Medicine

Samuel Hawgood, M.D. (2010)
University of California, San Francisco

Catherine C. Hedrick, Ph.D. (2011)
University of Virginia

Nigel Mackman, Ph.D. (2013)
University of North Carolina

Catherine S. Manno, M.D. (2013)
New York University

Fernando D. Martinez, M.D. (2013)
University of Arizona

Christine S. Moravec, Ph.D. (2012)
Cleveland Clinic Foundation

David J. Pinsky, M.D. (2012)
University of Michigan

Nanduri R. Prabhakar, Ph.D. (2012)
University of Chicago

Frank C. Sciurba, M.D. (2013)
University of Pittsburgh

Curt D. Sigmund, Ph.D. (2011)
University of Iowa

Nancy Speck, Ph.D. (2013)
University of Pennsylvania

Arun Srivastava, Ph.D. (2011)
University of Florida

Robert A. Wise, M.D. (2010)
Johns Hopkins University School of Medicine

Katherine E. Yutzey, Ph.D. (2010)
Children’s Hospital Research Foundation

Clinical Trials Review Committee

Chair:  John J. Reilly, M.D., University of Pittsburgh

Scientific Review Officer:  Keary A. Cope, Ph.D., Health Science Administrator, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–2222

The Clinical Trials Review Committee provides initial technical merit review for the NHLBAC and the Director of the NHLBI on clinical trial applications for the support of studies to evaluate preventive or therapeutic measures of blood, cardiovascular, or lung diseases.

Membership*

Walter T. Ambrosius, Ph.D. (2010)
Wake Forest University

Carlos Arturo Camargo, Jr., M.D., Dr.P.H. (2012)
Massachusetts General Hospital

Ivan Chan, Ph.D. (2010)
Merck Research Laboratories

Mark D. Eisner, M.D. (2013)
University of California, San Francisco

Scott S. Emerson, M.D., Ph.D. (2011)
University of Washington

Kenneth E. Freedland, Ph.D. (2011)
Washington University School of Medicine

Robert A. Harrington, M.D. (2010)
Duke School of Medicine

Wendy J. Mack, Ph.D. (2011)
University of Southern California

Karen L. Margolis, M.D. (2011)
Health Partners Research Foundation

Lori J. Mosca, M.D., Ph.D. (2013)
Columbia University Medical Center

Pamela Ouyang, M.D. (2010)
Johns Hopkins University School of Medicine

Arshed A. Quyyumi, M.D. (2013)
Emory University School of Medicine

Margaret M. Redfield, M.D. (2013)
Mayo Clinic

Amy Dana Shapiro, M.D. (2012)
Indiana Hemophilia and Thrombosis Center, Inc.

Stanley J. Szefler, M.D. (2012)
National Jewish Health Medical & Research Center

Back to Top

NHLBI Institutional Training Mechanism Review Committee

Chair:  William C. Balke, M.D., University of Kentucky

Scientific Review Officer:  Charles Joyce, Ph.D., Health Science Administrator, Division of Extramural Research Activities, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–435–0291

The NHLBI Institutional Training Mechanism Review Committee provides initial technical merit review for the NHLBAC and the Director of the NHLBI on training applications that provide predoctoral, postdoctoral, and short-term research training at academic institutions.

Membership*

Janis L. Abkowitz, M.D. (2013)
University of Washington Medical Center

Ifeanyi J. Arinze, Ph.D. (2012)
Meharry Medical College

Meredith Bond, Ph.D. (2013)
University of Maryland School of Medicine

Linda J. Burns, M.D. (2011)
University of Minnesota

David M. Center, M.D. (2011)
Boston University Medical Campus

David M. Guidot, M.D. (2010)
Emory University

Carlton A. Hornung, Ph.D. (2010)
University of Louisville

Gary W. Hunninghake, M.D. (2013)
University of Iowa

Craig K. Kent, M.D. (2010)
Weill Medical College of Cornell University

Kirk U. Knowlton, M.D. (2013)
University of California, San Diego

Alice H. Lichtenstein, D.S.C. (2013)
Tufts University

Bertram H. Lubin, M.D. (2010)
Children’s Hospital Oakland Research Institute

Russell V. Luepker, M.D. (2012)
University of Minnesota

Jonathan C. Makielski, M.D. (2012)
University of Wisconsin Hospitals and Clinics

Josef  T. Prchal, M.D. (2012)
University of Utah

Sharon Rounds, M.D. (2010)
Brown University

Robin Shandas, Ph.D. (2012)
University of Colorado Health Sciences Center

Sanjeev G. Shroff, Ph.D. (2010)
University of Pittsburgh

Brian Smith, M.D. (2011)
Yale University School of Medicine

Mary I. Townsley, Ph.D. (2012)
University of South Alabama

Donna H. Wang, M.D. (2011)
Michigan State University

Scott T. Weiss, M.D. (2011)
Brigham and Women’s Hospital

Reen Wu, Ph.D. (2011)
University of California at Davis

Back to Top

National Heart, Lung, and Blood Institute Special Emphasis Panel

The Institute has established the NHLBI Special Emphasis Panel (SEP) to perform initial peer review of applications and proposals that were previously handled by ad hoc committees.  Concept review, previously handled by divisional program advisory committees, has also been incorporated into the SEP system.  The SEP, which has neither a fixed membership nor a set meeting schedule, is constituted to provide required peer review expertise at precisely the time that it is needed.

Board of Scientific Counselors

Chair:  Gary K. Owens, M.D., Ph.D., University of Virginia School of Medicine

Executive Secretary:  Robert S. Balaban, Ph.D., Director, Laboratory Research Program, NHLBI, National Institutes of Health, Bethesda, MD 20892; 301–496–2116

The Board of Scientific Counselors advises the Director and the Deputy Director for Intramural Research, NIH, and the Directors of NHLBI and the Division of Intramural Research, NHLBI, on the intramural research programs of the NHLBI.

Membership*

Stephen Black, Ph.D. (2011)
Medical College of Georgia

Kenneth R. Chien, M.D., Ph.D. (2012)
Harvard University

Michael I. Kotlikoff, V.M.D., Ph.D. (2013)
Cornell University

Aldons Jake Lusis, Ph.D. (2013)
University of California, Los Angeles

Elizabeth M. McNally, M.D., Ph.D. (2010)
University of Chicago

Back to Top

« Factbook Table of Contents